Clinical Trials on Lymphoma in Canada
Total 638 results
-
Grupo Oncológico para el Tratamiento y el Estudio...Unknown
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Trans Tasman Radiation Oncology GroupAustralasian Leukaemia and Lymphoma GroupCompletedFollicular LymphomaAustralia, New Zealand, Canada
-
Beckman Coulter, Inc.CompletedLeukemia-LymphomaCanada, United States, Germany
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedMelanoma | Lymphoma | Lymphoma, Non-Hodgkin | Carcinoma, Basal CellCanada
-
Astellas Pharma IncTerminatedLymphoma, Large-Cell, Diffuse | Lymphoma, B-Cell RefractoryFrance, Spain, United States, Canada
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
Fundación Academia Española de DermatologíaRecruitingLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, B-Cell, Marginal Zone | Lymphoma, T-Cell, Cutaneous | Sezary Syndrome | Lymphoma, Extranodal NK-T-CellSpain
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, France, Poland, Belgium, Germany, Spain, Argentina, Colombia, Israel, Portugal, Russian Federation, Turkey, Ukraine, Canada, Greece, Sweden, Korea, Republic of, United Kingdom, Brazil, Mexico, Czechia
-
Grupo Español de Linfomas y Transplante Autólogo...Unknown
-
Dana-Farber Cancer InstituteBoston Children's HospitalTerminatedAcute Lymphoblastic LeukemiaUnited States, Puerto Rico, Canada
-
Hoffmann-La RocheActive, not recruitingNon-Hodgkin Lymphoma | B-Cell LymphomaUnited States, Italy, Canada, Australia, Spain, Denmark, France, Germany, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
University of British ColumbiaAmgenTerminatedMinimal Residual Disease | B-cell Adult Acute Lymphoblastic Leukemia | Stem Cell LeukemiaCanada
-
Pharmacyclics Switzerland GmbHJanssen Biotech, Inc., including Johnson & JohnsonEnrolling by invitationLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Solid Tumor | Leukemia, B-cell | Graft Vs Host DiseaseUnited States, Spain, Taiwan, United Kingdom, Australia, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, France, Turkey, Czechia, Hungary, Poland, Sweden
-
GlaxoSmithKlineCompletedLymphoma, Non-HodgkinCanada
-
University Health Network, TorontoThe Leukemia and Lymphoma SocietyCompletedAcute Myeloid Leukemia | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Hematologic Malignancy | Chronic Myelogenous Leukemia | Myelodysplasia | Hodgkin's DiseaseCanada
-
Canadian Cancer Trials GroupPfizerCompletedRefractory Lymphoma | Recurrent Lymphoma | Solid Tumours | Central Nervous SystemCanada
-
Inex PharmaceuticalsCompletedLymphomaUnited States, Canada
-
AHS Cancer Control AlbertaWithdrawn
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingOsteosarcoma | Lymphoblastic Lymphoma | Recurrent Lymphoma | Recurrent Malignant Neoplasm | Hodgkin Lymphoma in Remission | Leukemia in Remission | Recurrent LeukemiaUnited States, Australia, Canada, Puerto Rico
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
NCIC Clinical Trials GroupCompleted
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Boston Children's Hospital; NCIC Clinical Trials...Active, not recruiting
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Dana-Farber Cancer InstituteServierActive, not recruitingAcute Lymphoblastic Leukemia, PediatricUnited States, Canada
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic LeukemiaBelgium, Germany, France, Austria, Canada, Italy, Japan, Norway, Spain
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
Gilead SciencesTerminatedAcute Lymphoblastic LeukemiaUnited States, Canada, Germany
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
Sunnybrook Health Sciences CentreQueen's University; The Leukemia and Lymphoma SocietyRecruitingLymphoma | Chemotherapeutic ToxicityCanada
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedDisease, HodgkinUnited States, Canada
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, AnaplasticUnited States, France, Canada, Belgium, United Kingdom
-
Epizyme, Inc.Celgene CorporationCompletedAcute Myeloid Leukemia | Leukemia | Acute Lymphocytic Leukemia | Acute LeukemiasUnited States, Canada
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States, United Kingdom, Canada, France, Italy, Belgium
-
Omnitura Therapeutics, Inc.Completed
-
Acerta Pharma BVAstraZenecaActive, not recruitingNon Hodgkin LymphomaUnited States, Canada, Italy
-
AmgenCompletedHigh-risk Diffuse Large B-Cell LymphomaUnited States, Canada, Germany, Spain, France, United Kingdom
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
Genzyme, a Sanofi CompanyCompletedLymphoma, Non-Hodgkin | Multiple MyelomaCanada
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States, Japan, Australia, Italy, Canada, Germany, Norway, Netherlands, France, Austria
-
Merck Sharp & Dohme LLCActive, not recruitingHodgkin's Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)Canada, United States, Brazil, Czechia, France, Italy, Poland, Russian Federation, South Africa, Turkey, Ukraine
-
Pharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small-Cell LymphomaUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
St. Jude Children's Research HospitalBaylor College of Medicine; Gateway for Cancer ResearchActive, not recruitingAcute Lymphoblastic LeukemiaUnited States, Canada